Monument Therapeutics
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Block 1 g28 Alderley Park Congleton Rd, ...Website
www.monumenttx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Monument Therapeutics
Monument Therapeutics applies a unique novel drug development strategy, leveraging digital assessments of cognition to match patients with new pharmaceutical treatments. Their flagship product, MT1988, targets the cognitive symptoms of schizophrenia, which are extremely costly for society and profoundly impact the affected individuals and their quality of life.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Monument Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Monument Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Monument Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Monument Therapeutics recently announced quarterly report
Check out if Monument Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Monument Therapeutics launches new products
Funding: Get notified immidiatlly once Monument Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Monument Therapeutics
Check if Monument Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Monument Therapeutics
Find more new buyers
Compare Similar Companies to Monument Therapeutics
Compare insights from companies similar to Monument Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Monument Therapeutics
<$5M
1-10
Private
$6M
2019
N/A
Company Profile Activity
Activity Insights
Monument Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Monument Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Monument Therapeutics.
Monument Therapeutics financials insights
Gather financial insights about Monument Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$3.6M
2024
Private Equity
$1.3M
2025
Other Financing Round
$1.1M
Monument Therapeutics Tech Stack
A closer look at the technologies used by Monument Therapeutics
See more technologies
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Monument Therapeutics
Sign Up For FreeTo access detailed company insights
Monument Therapeutics applies a unique novel drug development strategy, leveraging digital assessments of cognition to match patients with new pharmaceutical treatments. Their flagship product, MT1988, targets the cognitive symptoms of schizophrenia, which are extremely costly for society and profoundly impact the affected individuals and their qua... Read More
